机构地区:[1]Department of Cardiology, Renmin Hospital, Wuhan University, Wuhan 430073, China [2]Department of Cardiology, Zhongnan Hospital, Wuhan University, Wuhan 430071, China
出 处:《Acta Pharmacologica Sinica》2011年第4期465-477,共13页中国药理学报(英文版)
摘 要:Aim: To investigate the effects of diltiazem, an L-type calcium channel blocker, and propafenone, a sodium channel blocker, on the inactivation and recovery kinetics of fKvl.4, a potassium channel that generates the cardiac transient outward potassium current. Methods: The cRNA for fKvl.4hN, an N-terminal deleted mutant of the ferret Kvl.4 potassium channel, was injected into Xenopus oocytes to express the fKvl.4AN channel in these cells. Currents were recorded using a two electrode voltage clamp technique. Results: Diltiazem (10 to 1000 IJmol/L) inhibited the fKvl.4AN channel in a frequency-dependent, voltage-dependent, and concentration-dependent manner, suggesting an open channel block. The IC50 was 241.04±23.06 pmol/L for the fKvl.4hN channel (at +50 mV), and propafenone (10 to 500 μmol/L) showed a similar effect (IC5o=103.68±10,13 pmol/L). After application of diltiazem and propafenone, fKvl.4AN inactivation was hi-exponential, with a faster drug-induced inactivation and a slower C-type inactivation. Diltiazem increased the C-type inactivation rate and slowed recovery in fKvl.4hN channels. However, propafenone had no effect on either the slow inactivation time constant or the recovery. Conclusion: Diltiazem and propafenone accelerate the inactivation of the Kvl.4AN channel by binding to the open state of the channel Unlike propafenone, diltiazem slows the recovery of the Kvl.4AN channel.Aim: To investigate the effects of diltiazem, an L-type calcium channel blocker, and propafenone, a sodium channel blocker, on the inactivation and recovery kinetics of fKvl.4, a potassium channel that generates the cardiac transient outward potassium current. Methods: The cRNA for fKvl.4hN, an N-terminal deleted mutant of the ferret Kvl.4 potassium channel, was injected into Xenopus oocytes to express the fKvl.4AN channel in these cells. Currents were recorded using a two electrode voltage clamp technique. Results: Diltiazem (10 to 1000 IJmol/L) inhibited the fKvl.4AN channel in a frequency-dependent, voltage-dependent, and concentration-dependent manner, suggesting an open channel block. The IC50 was 241.04±23.06 pmol/L for the fKvl.4hN channel (at +50 mV), and propafenone (10 to 500 μmol/L) showed a similar effect (IC5o=103.68±10,13 pmol/L). After application of diltiazem and propafenone, fKvl.4AN inactivation was hi-exponential, with a faster drug-induced inactivation and a slower C-type inactivation. Diltiazem increased the C-type inactivation rate and slowed recovery in fKvl.4hN channels. However, propafenone had no effect on either the slow inactivation time constant or the recovery. Conclusion: Diltiazem and propafenone accelerate the inactivation of the Kvl.4AN channel by binding to the open state of the channel Unlike propafenone, diltiazem slows the recovery of the Kvl.4AN channel.
关 键 词:INACTIVATION RECOVERY Kv1.4 potassium channel DILTIAZEM PROPAFENONE two electrode voltage clamp technique
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...